Transcription_P53 signaling pathway

No Pathway Network information available for Transcription_P53 signaling pathway

Pathways in the Transcription_P53 signaling pathway SuperPath

#	Name	Source	Genes
1	Transcription_P53 signaling pathway	GeneGo (Thomson Reuters)	APEX1 ATM ATR BCL2 CDK2 CDKN1A CDKN2A CREBBP CTNNB1 DUSP1 DUSP16 E2F1 EP300 ERCC2 ERCC3 FHL2 FLT1 FOS GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 HDAC1 HDAC2 HSPB1 KAT2B KDR MAP2K4 MAP3K1 MAP4 MAPK10 MAPK8 MAPK9 MDM2 MMP2 MTA2 NFKB1 NFKB2 PIAS1 PIAS2 RANBP2 RB1 RBBP4 RBBP7 REL RELA RELB SUMO1 TDG TP53 VEGFA XPA XPC (see all 54) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	APEX1	Apurinic/Apyrimidinic Endodeoxyribonuclease 1	Protein Coding	1
2	ATM	ATM Serine/Threonine Kinase	Protein Coding	1
3	ATR	ATR Checkpoint Kinase	Protein Coding	1
4	BCL2	BCL2 Apoptosis Regulator	Protein Coding	1
5	CDK2	Cyclin Dependent Kinase 2	Protein Coding	1
6	CDKN1A	Cyclin Dependent Kinase Inhibitor 1A	Protein Coding	1
7	CDKN2A	Cyclin Dependent Kinase Inhibitor 2A	Protein Coding	1
8	CREBBP	CREB Binding Lysine Acetyltransferase	Protein Coding	1
9	CTNNB1	Catenin Beta 1	Protein Coding	1
10	DUSP1	Dual Specificity Phosphatase 1	Protein Coding	1
11	E2F1	E2F Transcription Factor 1	Protein Coding	1
12	EP300	EP300 Lysine Acetyltransferase	Protein Coding	1
13	ERCC2	ERCC Excision Repair 2, TFIIH Core Complex Helicase Subunit	Protein Coding	1
14	ERCC3	ERCC Excision Repair 3, TFIIH Core Complex Helicase Subunit	Protein Coding	1
15	FHL2	Four And A Half LIM Domains 2	Protein Coding	1
16	FLT1	Fms Related Receptor Tyrosine Kinase 1	Protein Coding	1
17	FOS	Fos Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
18	GTF2H1	General Transcription Factor IIH Subunit 1	Protein Coding	1
19	GTF2H2	General Transcription Factor IIH Subunit 2	Protein Coding	1
20	GTF2H3	General Transcription Factor IIH Subunit 3	Protein Coding	1
21	GTF2H4	General Transcription Factor IIH Subunit 4	Protein Coding	1
22	HDAC1	Histone Deacetylase 1	Protein Coding	1
23	HDAC2	Histone Deacetylase 2	Protein Coding	1
24	HSPB1	Heat Shock Protein Family B (Small) Member 1	Protein Coding	1
25	KDR	Kinase Insert Domain Receptor	Protein Coding	1
26	MAP4	Microtubule Associated Protein 4	Protein Coding	1
27	MDM2	MDM2 Proto-Oncogene	Protein Coding	1
28	MAP3K1	Mitogen-Activated Protein Kinase Kinase Kinase 1	Protein Coding	1
29	MMP2	Matrix Metallopeptidase 2	Protein Coding	1
30	NFKB1	Nuclear Factor Kappa B Subunit 1	Protein Coding	1
31	NFKB2	Nuclear Factor Kappa B Subunit 2	Protein Coding	1
32	MAPK8	Mitogen-Activated Protein Kinase 8	Protein Coding	1
33	MAPK9	Mitogen-Activated Protein Kinase 9	Protein Coding	1
34	MAPK10	Mitogen-Activated Protein Kinase 10	Protein Coding	1
35	RANBP2	RAN Binding Protein 2	Protein Coding	1
36	RB1	RB Transcriptional Corepressor 1	Protein Coding	1
37	RBBP4	RB Binding Protein 4, Chromatin Remodeling Factor	Protein Coding	1
38	RBBP7	RB Binding Protein 7, Chromatin Remodeling Factor	Protein Coding	1
39	REL	REL Proto-Oncogene, NF-KB Subunit	Protein Coding	1
40	RELA	RELA Proto-Oncogene, NF-KB Subunit	Protein Coding	1
41	RELB	RELB Proto-Oncogene, NF-KB Subunit	Protein Coding	1
42	MAP2K4	Mitogen-Activated Protein Kinase Kinase 4	Protein Coding	1
43	TDG	Thymine DNA Glycosylase	Protein Coding	1
44	TP53	Tumor Protein P53	Protein Coding	1
45	SUMO1	Small Ubiquitin Like Modifier 1	Protein Coding	1
46	VEGFA	Vascular Endothelial Growth Factor A	Protein Coding	1
47	XPA	XPA, DNA Damage Recognition And Repair Factor	Protein Coding	1
48	XPC	XPC Complex Subunit, DNA Damage Recognition And Repair Factor	Protein Coding	1
49	PIAS1	Protein Inhibitor Of Activated STAT 1	Protein Coding	1
50	KAT2B	Lysine Acetyltransferase 2B	Protein Coding	1
51	PIAS2	Protein Inhibitor Of Activated STAT 2	Protein Coding	1
52	MTA2	Metastasis Associated 1 Family Member 2	Protein Coding	1
53	DUSP16	Dual Specificity Phosphatase 16	Protein Coding	1
54	GTF2H5	General Transcription Factor IIH Subunit 5	Protein Coding	1

Disorders associated with Transcription_P53 signaling pathway SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Ovarian cancer	Enrichment	ATM, CDKN2A, CTNNB1, ERCC2, ERCC3, MAP3K1, RB1, TP53, XPA, XPC	16.00
2	Bladder cancer	Enrichment	ATM, CDKN1A, CDKN2A, CTNNB1, ERCC2, RB1, TP53	10.81
3	Xeroderma pigmentosum, variant type	Enrichment	ERCC2, ERCC3, XPA, XPC	7.14
4	Li-fraumeni syndrome	Enrichment	CDKN2A, MDM2, TP53	5.93
5	Adrenocortical carcinoma	Enrichment	CDKN2A, CTNNB1, TP53	5.93
6	Trichothiodystrophy	Enrichment	ERCC2, ERCC3, GTF2H5	5.31
7	Lip and oral cavity carcinoma	Enrichment	CDKN2A, RB1, TP53	4.89
8	Xeroderma pigmentosum, complementation group a	Enrichment	XPA, XPC	4.81
9	Osteogenic sarcoma	Enrichment	RB1, TP53	4.33
10	Squamous cell carcinoma	Enrichment	RB1, TP53	4.33
11	Adenocarcinoma	Enrichment	ATM, TP53	4.33
12	Bone osteosarcoma	Enrichment	RB1, TP53	4.33
13	Hepatoblastoma	Enrichment	CTNNB1, ERCC2, TP53	4.12
14	Small cell cancer of the lung	Enrichment	RB1, TP53	4.03
15	Craniopharyngioma	Enrichment	CTNNB1, ERCC2	4.03
16	Pancreatic cancer	Enrichment	ATM, CDKN2A, TP53	3.89
17	Xeroderma pigmentosum-cockayne syndrome complex	Enrichment	ERCC2, ERCC3	3.81
18	Inherited cancer-predisposing syndrome	Enrichment	ATM, CDKN2A, ERCC3, RB1, TP53	3.76
19	Rubinstein-taybi syndrome 1	Enrichment	CREBBP, EP300	3.64
20	Chromosome 16p13.3 deletion syndrome, proximal	Enrichment	CREBBP, EP300	3.64
21	Gallbladder cancer	Enrichment	CTNNB1, TP53	3.49
22	Common variable immunodeficiency	Enrichment	NFKB1, NFKB2	3.49
23	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	CDKN2A, TP53	3.49
24	Colorectal cancer	Enrichment	ATM, CTNNB1, EP300, TP53	3.41
25	Adult hepatocellular carcinoma	Enrichment	CTNNB1, TP53	3.26
26	Gastric cancer	Enrichment	ATM, CDKN2A, TP53	3.18
27	Leukemia, chronic lymphocytic	Enrichment	ATM, TP53	3.16
28	Lung cancer susceptibility 3	Enrichment	RB1, TP53	2.86
29	Myeloma, multiple	Enrichment	ATM, CREBBP, TP53	2.85
30	Corpus callosum, agenesis of	Enrichment	CREBBP, ERCC2	2.80
31	Isolated corpus callosum agenesis	Enrichment	CREBBP, ERCC2	2.80
32	Rare genetic intellectual disability	Enrichment	CREBBP, EP300	2.80
33	Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome	Enrichment	CREBBP, ERCC2	2.80
34	Gliosarcoma	Enrichment	ATM, TP53	2.74
35	Giant cell glioblastoma	Enrichment	ATM, TP53	2.69
36	Diffuse large b-cell lymphoma	Enrichment	CREBBP, TP53	2.59
37	Hepatocellular carcinoma	Enrichment	CTNNB1, TP53	2.47
38	Tooth agenesis	Enrichment	RANBP2, SUMO1	2.47
39	Spermatogenic failure, x-linked, 9	Enrichment	RBBP7	2.40
40	Xeroderma pigmentosum, complementation group b	Enrichment	ERCC3	2.40
41	Seckel syndrome 1	Enrichment	ATR	2.40
42	46,xy sex reversal 6	Enrichment	MAP3K1	2.40
43	Accelerated tumor formation	Enrichment	MDM2	2.40
44	Immunodeficiency 92	Enrichment	REL	2.40
45	Lessel-kubisch syndrome	Enrichment	MDM2	2.40
46	Bone marrow failure syndrome 5	Enrichment	TP53	2.40
47	Orofacial cleft 10	Enrichment	SUMO1	2.40
48	Papilloma of choroid plexus	Enrichment	TP53	2.40
49	Basal cell carcinoma 7	Enrichment	TP53	2.40
50	Xeroderma pigmentosum, complementation group d	Enrichment	ERCC2	2.40
51	Anaplastic thyroid carcinoma	Enrichment	TP53	2.40
52	Microvascular complications of diabetes 1	Enrichment	VEGFA	2.40
53	Trichothiodystrophy 2, photosensitive	Enrichment	ERCC3	2.40
54	Xeroderma pigmentosum group b	Enrichment	ERCC3	2.40
55	Charcot-marie-tooth disease, axonal, type 2f	Enrichment	HSPB1	2.40
56	Cerebrooculofacioskeletal syndrome 2	Enrichment	ERCC2	2.40
57	Cutaneous telangiectasia and cancer syndrome, familial	Enrichment	ATR	2.40
58	Trichothiodystrophy 3, photosensitive	Enrichment	GTF2H5	2.40
59	Endometrial serous adenocarcinoma	Enrichment	ATM	2.40
60	Ductal carcinoma in situ	Enrichment	TP53	2.40
61	Deficiency in anterior pituitary function - variable immunodeficiency syndrome	Enrichment	NFKB2	2.40
62	Immunodeficiency 53	Enrichment	RELB	2.40
63	Menke-hennekam syndrome 1	Enrichment	CREBBP	2.40
64	Thyroid gland undifferentiated carcinoma	Enrichment	TP53	2.40
65	Tufted angioma of skin	Enrichment	KDR	2.40
66	Trilateral retinoblastoma	Enrichment	RB1	2.40
67	Small-cell carcinoma of the ovary of hypercalcemic type	Enrichment	TP53	2.40
68	Adenoid ameloblastoma	Enrichment	CTNNB1	2.40
69	Cdkn2a cancer predisposition	Enrichment	CDKN2A	2.40
70	Rubinstein-taybi syndrome due to 16p13.3 microdeletion	Enrichment	CREBBP	2.40
71	Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype	Enrichment	TP53	2.40
72	B-cell non-hodgkin lymphoma	Enrichment	ATM	2.40
73	Choroid plexus cancer	Enrichment	TP53	2.40
74	Xeroderma pigmentosum group d	Enrichment	ERCC2	2.40
75	Menke-hennekam syndrome	Enrichment	CREBBP	2.40
76	Pleomorphic xanthoastrocytoma	Enrichment	TP53	2.40
77	Familial acute necrotizing encephalopathy	Enrichment	RANBP2	2.40
78	Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome	Enrichment	ATR	2.40
79	Microcystic stromal tumor	Enrichment	CTNNB1	2.40
80	Lung oat cell carcinoma	Enrichment	RB1	2.40
81	Prostate cancer	Enrichment	ATM, TP53	2.23
82	Melanoma-astrocytoma syndrome	Enrichment	CDKN2A	2.10
83	Adrenocortical carcinoma, hereditary	Enrichment	TP53	2.10
84	Thumb deformity	Enrichment	CREBBP	2.10
85	Osteopathia striata with cranial sclerosis	Enrichment	CTNNB1	2.10
86	Xeroderma pigmentosum, complementation group c	Enrichment	XPC	2.10
87	Cervical cancer	Enrichment	TP53	2.10
88	Melanoma, cutaneous malignant 2	Enrichment	CDKN2A	2.10
89	Neuronopathy, distal hereditary motor, autosomal dominant 3	Enrichment	HSPB1	2.10
90	Chromosome 13q14 deletion syndrome	Enrichment	RB1	2.10
91	Angioma, tufted	Enrichment	KDR	2.10
92	Lymphoma, hodgkin, classic	Enrichment	TP53	2.10
93	Immunodeficiency, common variable, 12, with autoimmunity	Enrichment	NFKB1	2.10
94	Immunodeficiency, common variable, 10	Enrichment	NFKB2	2.10
95	Cardiac valvular dysplasia, x-linked	Enrichment	ATM	2.10
96	Autoinflammatory disease, familial, behcet-like 3	Enrichment	RELA	2.10
97	Menke-hennekam syndrome 2	Enrichment	EP300	2.10
98	Intravascular large b-cell lymphoma	Enrichment	BCL2	2.10
99	Childhood hepatocellular carcinoma	Enrichment	CTNNB1	2.10
100	Rela fusion-positive ependymoma	Enrichment	RELA	2.10
101	Acute myeloid leukemia with kat6a-crebbp fusion	Enrichment	CREBBP	2.10
102	Melanoma-pancreatic cancer syndrome	Enrichment	CDKN2A	2.10
103	Congenital fibrosarcoma	Enrichment	TP53	2.10
104	High grade glioma	Enrichment	ATM	2.10
105	Li-fraumeni syndrome 1	Enrichment	TP53	2.10
106	Sarcoma	Enrichment	TP53	2.10
107	Cervix carcinoma	Enrichment	TP53	2.10
108	Hodgkin's lymphoma	Enrichment	TP53	2.10
109	T-cell prolymphocytic leukemia	Enrichment	ATM	2.10
110	Xeroderma pigmentosum group c	Enrichment	XPC	2.10
111	Juvenile nasopharyngeal angiofibroma	Enrichment	CTNNB1	2.10
112	Teratoma	Enrichment	CTNNB1	2.10
113	Familial retinoblastoma	Enrichment	RB1	2.10
114	Common variable immunodeficiency 12	Enrichment	NFKB1	2.10
115	Acute necrotizing encephalopathy of childhood	Enrichment	RANBP2	2.10
116	Pleomorphic rhabdomyosarcoma	Enrichment	TP53	2.10
117	Desmoid disease, hereditary	Enrichment	CTNNB1	1.92
118	Retinoblastoma	Enrichment	RB1	1.92
119	Ataxia-telangiectasia	Enrichment	ATM	1.92
120	Polycythemia vera	Enrichment	ATM	1.92
121	Trichothiodystrophy 1, photosensitive	Enrichment	ERCC2	1.92
122	Multicentric osteolysis, nodulosis, and arthropathy	Enrichment	MMP2	1.92
123	Nasopharyngeal carcinoma	Enrichment	TP53	1.92
124	Neurodevelopmental disorder with spastic diplegia and visual defects	Enrichment	CTNNB1	1.92
125	Woolly hair, autosomal recessive 3	Enrichment	RB1	1.92
126	Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive	Enrichment	RANBP2	1.92
127	Anus, imperforate	Enrichment	CTNNB1	1.92
128	Exudative vitreoretinopathy 7	Enrichment	CTNNB1	1.92
129	Hypotrichosis 8	Enrichment	RB1	1.92
130	Tethered spinal cord syndrome	Enrichment	CREBBP	1.92
131	Koolen-de vries syndrome	Enrichment	ATM	1.92
132	Desmoid tumor	Enrichment	CTNNB1	1.92
133	High-grade b-cell lymphoma double-hit/triple-hit	Enrichment	BCL2	1.92
134	Dedifferentiated liposarcoma	Enrichment	MDM2	1.92
135	Atypical teratoid rhabdoid tumor	Enrichment	TP53	1.92
136	Anaplastic astrocytoma	Enrichment	TP53	1.92
137	Intraocular pressure quantitative trait locus	Enrichment	CREBBP	1.92
138	Well-differentiated liposarcoma	Enrichment	MDM2	1.92
139	Hereditary breast carcinoma	Enrichment	ATM, TP53	1.88
140	Ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive	Enrichment	RANBP2	1.80
141	Thyroid cancer, nonmedullary, 1	Enrichment	TP53	1.80
142	Immunodeficiency, common variable, 1	Enrichment	NFKB2	1.80
143	Pilomatrixoma	Enrichment	CTNNB1	1.80
144	Lynch syndrome 4	Enrichment	RB1	1.80
145	Alazami syndrome	Enrichment	CTNNB1	1.80
146	Congenital generalized lipodystrophy	Enrichment	FOS	1.80
147	Mantle cell lymphoma	Enrichment	ATM	1.80
148	Lung sarcomatoid carcinoma	Enrichment	TP53	1.80
149	Ectodermal dysplasia	Enrichment	RANBP2	1.80
150	Embryonal rhabdomyosarcoma	Enrichment	TP53	1.80
151	Oculomotor apraxia	Enrichment	ATM	1.80
152	Ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant	Enrichment	RANBP2	1.70
153	Neuronopathy, distal hereditary motor, autosomal dominant 2	Enrichment	HSPB1	1.70
154	Exudative vitreoretinopathy 1	Enrichment	CTNNB1	1.70
155	Rhabdomyosarcoma 2	Enrichment	TP53	1.70
156	Rubinstein-taybi syndrome 2	Enrichment	EP300	1.70
157	Pre-eclampsia	Enrichment	FLT1	1.70
158	Follicular lymphoma	Enrichment	BCL2	1.70
159	Lymphoma	Enrichment	TP53	1.70
160	Glioblastoma	Enrichment	ATM	1.70
161	Histiocytoid hemangioma	Enrichment	FOS	1.70
162	Acute megakaryocytic leukemia	Enrichment	TP53	1.70
163	Autosomal recessive hypohidrotic ectodermal dysplasia syndrome	Enrichment	RANBP2	1.70
164	Hereditary breast ovarian cancer syndrome	Enrichment	ATM, TP53	1.69
165	Weyers acrofacial dysostosis	Enrichment	CTNNB1	1.63
166	Cerebrooculofacioskeletal syndrome 1	Enrichment	ERCC2	1.63
167	Hemangioma, capillary infantile	Enrichment	KDR	1.63
168	Inflammatory myofibroblastic tumor	Enrichment	RANBP2	1.63
169	Clear cell renal cell carcinoma	Enrichment	ATM	1.63
170	Breast adenocarcinoma	Enrichment	TP53	1.63
171	Lung squamous cell carcinoma	Enrichment	CDKN2A	1.63
172	Hypertrichosis	Enrichment	CREBBP	1.63
173	Esophageal cancer	Enrichment	TP53	1.56
174	Multiple endocrine neoplasia, type i	Enrichment	CDKN1A	1.56
175	Mitochondrial dna depletion syndrome 4a	Enrichment	RANBP2	1.56
176	Squamous cell carcinoma, head and neck	Enrichment	TP53	1.56
177	Renal cell carcinoma, papillary, 1	Enrichment	ATM	1.56
178	Essential thrombocythemia	Enrichment	TP53	1.56
179	Glioma susceptibility 1	Enrichment	TP53	1.50
180	Lymphoma, non-hodgkin, familial	Enrichment	TP53	1.50
181	Mitochondrial dna depletion syndrome 4b	Enrichment	RANBP2	1.50
182	Lennox-gastaut syndrome	Enrichment	MAPK10	1.50
183	Exudative vitreoretinopathy	Enrichment	CTNNB1	1.50
184	Charge syndrome	Enrichment	EP300	1.45
185	Inflammatory bowel disease 1	Enrichment	ERCC2	1.45
186	Primary hyperaldosteronism	Enrichment	TP53	1.45
187	Colonic benign neoplasm	Enrichment	ATM	1.45
188	Hypotrichosis simplex	Enrichment	ERCC2	1.45
189	Breast cancer	Enrichment	ATM, TP53	1.45
190	Lynch syndrome 1	Enrichment	ATM	1.41
191	Ciliary dyskinesia, primary, 3	Enrichment	NFKB1	1.41
192	Melanoma	Enrichment	CDKN2A	1.41
193	Familial colorectal cancer	Enrichment	TP53	1.41
194	Immune deficiency disease	Enrichment	ATM	1.37
195	Leukemia, acute lymphoblastic	Enrichment	CDKN2A	1.37
196	Myelodysplastic syndrome	Enrichment	TP53	1.37
197	46,xy complete gonadal dysgenesis	Enrichment	MAP3K1	1.37
198	Uterine corpus cancer	Enrichment	ATM	1.37
199	Familial colorectal cancer type x	Enrichment	ATM	1.37
200	Breast-ovarian cancer, familial 1	Enrichment	ATM	1.30
201	Medulloblastoma	Enrichment	CTNNB1	1.26
202	Seckel syndrome	Enrichment	ATR	1.26
203	Heart disease	Enrichment	CREBBP	1.26
204	46,xy partial gonadal dysgenesis	Enrichment	MAP3K1	1.26
205	Renal cell carcinoma, nonpapillary	Enrichment	ATM	1.24
206	Polydactyly, postaxial, type a1	Enrichment	EP300	1.24
207	Rhabdomyosarcoma	Enrichment	TP53	1.21
208	Melanoma, cutaneous malignant 1	Enrichment	CDKN2A	1.18
209	Polycystic liver disease	Enrichment	CTNNB1	1.18
210	Autosomal dominant polycystic liver disease	Enrichment	CTNNB1	1.18
211	Congenital nervous system abnormality	Enrichment	CREBBP, CTNNB1	1.18
212	Nervous system disease	Enrichment	CREBBP, CTNNB1	1.18
213	Leukodystrophy	Enrichment	ERCC2	1.12
214	Endometrial cancer	Enrichment	ATM	1.09
215	Microcephaly	Enrichment	CTNNB1, EP300	1.07
216	Diamond-blackfan anemia 1	Enrichment	TP53	1.06
217	Precursor t-cell acute lymphoblastic leukemia	Enrichment	CDKN2A	1.06
218	Scoliosis	Enrichment	CREBBP	1.04
219	Tetralogy of fallot	Enrichment	KDR	1.01
220	Nephronophthisis	Enrichment	PIAS1	0.91
221	Diamond-blackfan anemia	Enrichment	TP53	0.87
222	Leukemia, acute myeloid	Enrichment	TP53	0.83
223	Charcot-marie-tooth disease	Enrichment	HSPB1	0.82
224	Familial isolated dilated cardiomyopathy	Enrichment	FHL2	0.72
225	Primary ovarian insufficiency	Enrichment	KDR	0.68
226	Autism	Enrichment	CREBBP	0.60

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Transcription_P53 signaling pathway

Pathway Network for Transcription_P53 signaling pathway

Member Pathways for Transcription_P53 signaling pathway

Pathways in the Transcription_P53 signaling pathway SuperPath

Associated Genes for Transcription_P53 signaling pathway

Associated Disorders for Transcription_P53 signaling pathway

Disorders associated with Transcription_P53 signaling pathway SuperPath

STRING Interaction Network for Transcription_P53 signaling pathway

Sources for Transcription_P53 signaling pathway